XANAX*(blend)
XANAX is a triazolobenzodiazepine indicated for the treatment of anxiety and panic disorders. It is mainly metabolized by CYP3As and so is contraindicated with CYP3A inhibitors like ketoconazole and itraconazole. Benzodiazepine treatment should be stopped
Item Code: LF-0077
RECOMMEND

Cannabidiol (CBD).POWDER
Cannabidiol (CBD) is a phytocannabinoid discovered in 1940. It is one of 113 identified cannabinoids in cannabis plants and accounts for up to 40% of the plant's extract.In 2018, clinical research on cannabidiol included preliminary studies of anxiety, co
$
7.00
VIEW MORE

A-PCYP .LARGE CRYSTAL
alpha -pcyp is a synthetic stimulant drug of the cathinone class developed in the middle of 2019 which has been reported as a novel designer drug.
α-pcyp is a substituted homologue of α-PVP, having an cyclohexane replaced the alkyl side chain,regarding t
$
3.20
VIEW MORE

O-AMKD. FUMARATE
Acetoxymethylketobemidone (O-AMKD) is an opioid analgesic that is an acetylated derivative of ketobemidone. It was developed in the 1950s during research into analgrsic of pethidine and was assessed by the United Nations Office on Drugs and Crime but was
$
9.60
VIEW MORE

BTCP. CRYSTAL
Benocyclidine (BTCP) is a derivative of phencyclidine with a benzothiophenyl group instead of a phenyl ring. It acts as a potent and selective dopamine reuptake inhibitor (IC50 = 8 nM) with negligible affinity for the NMDA receptor-linked phencyclidine r
$
6.80
VIEW MORE
Customer Reviews